|
STAM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64523950019202E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.42634859057989E-12 |
| Normal-vs-Stage2 |
7.2877999968135E-08 |
| Normal-vs-Stage3 |
2.32125429988628E-12 |
| Normal-vs-Stage4 |
2.84516854520689E-12 |
| Stage1-vs-Stage2 |
5.671800E-01 |
| Stage1-vs-Stage3 |
1.019170E-01 |
| Stage1-vs-Stage4 |
1.398250E-02 |
| Stage2-vs-Stage3 |
5.676000E-01 |
| Stage2-vs-Stage4 |
1.346970E-01 |
| Stage3-vs-Stage4 |
2.563600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02140518265514E-14 |
| Normal-vs-AfricanAmerican |
4.922300E-03 |
| Normal-vs-Asian |
3.04979996812449E-09 |
| Caucasian-vs-AfricanAmerican |
5.867900E-02 |
| Caucasian-vs-Asian |
8.883200E-01 |
| AfricanAmerican-vs-Asian |
1.440780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.24931184789057E-13 |
| Normal-vs-Female |
2.68685074189534E-12 |
| Male-vs-Female |
1.803050E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.04639988182964E-10 |
| Normal-vs-Age(41-60Yrs) |
1.0387246618393E-12 |
| Normal-vs-Age(61-80Yrs) |
1.68339786554839E-11 |
| Normal-vs-Age(81-100Yrs) |
1.076540E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.122000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.320190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.890200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.354800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.870200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.720800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.016100E-02 |
| Classical-VS-Follicular |
3.424000E-01 |
| Classical-VS-Other |
2.080800E-01 |
| Classical-VS-Normal |
8.46267500520526E-12 |
| Tall-VS-Follicular |
1.571970E-01 |
| Tall-VS-Other |
8.129200E-01 |
| Tall-VS-Normal |
1.78570003228629E-09 |
| Follicular-VS-Other |
4.115800E-01 |
| Follicular-VS-Normal |
3.90559995455675E-09 |
| Other-VS-Normal |
3.409100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.01487740223183E-13 |
| Normal-vs-N1 |
1.0639000791457E-10 |
| N0-vs-N1 |
3.089600E-01 |
|
|
